SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001095811-00-000395
Filing Date
2000-02-25
Accepted
2000-02-25 00:00:00
Documents
5
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K405 187107
2 AMENDMENT NO.2 TO EMPLOYMENT AGREEMENT EX-10.6 14167
3 SUPPLEMENT EMPLOYMENT OFFER LETTER EX-10.40 5847
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS EX-23.1 851
5 FINANCIAL DATA SCHEDULE EX-27 2113
  Complete submission text file 0001095811-00-000395.txt   211965
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-24274 | Film No.: 553611
SIC: 2836 Biological Products, (No Diagnostic Substances)